

Contract Manufacture Organization (CMO) Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Contract Manufacturing Organization (CMO) market is experiencing significant growth, driven by increasing demand for pharmaceutical outsourcing and biotechnological advancements. The global CMO market size is projected to reach approximately $100 billion by 2027, reflecting robust industry expansion amid evolving regulatory landscapes and rising costefficiency needs among manufacturers.
Request Sample Report
◍ Lonza
◍ Boehringer Ingelheim
◍ Catalent
◍ Baxter
◍ AbbVie
◍ Pfizer
◍ Evonik
◍ Fareva group
◍ Aenova
◍ Almac
◍ Delpharm
◍ Recipharm
◍ Aesica
◍ NIPRO CORPORATION
◍ Daito Pharmaceutical
◍ Teva API
◍ Esteve Quimica
◍ Euticals
The Contract Manufacturing Organization (CMO) market features key players like Lonza, Boehringer Ingelheim, and Catalent, providing essential manufacturing services to pharma firms. These companies enable faster drug development, reduce costs, and enhance efficiency, driving market growth. Various firms report substantial revenues:
- Lonza: $5.7 billion
- Catalent: $3.3 billion
- Recipharm: $1.5 billion
◍ Active Pharmaceutical Ingredients (APIs)
◍ Finished Dose Formulations (FDFs) ◍ Pharmaceutical Industry
Biotechnology ◍ Medical Device Industry
Request Sample Report
Request Sample Report
$ X Billion USD